Nader Francois

CIK 00013653439 companiesMIAMI, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001365343

Recent Transactions

50 trades

Award
Moderna, Inc.$MRNA
Restricted Stock Units
2025-04-30+12,174→ 12,174 total
Award
Moderna, Inc.$MRNA
Stock Option (Right to Buy)
2025-04-30+6,378→ 6,378 total
Award
Moderna, Inc.$MRNA
Stock Option (Right to Buy)
2024-05-06+7,557→ 7,557 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2023-06-13+41,000→ 41,000 total
Award
Moderna, Inc.$MRNA
Stock Option (Right to Buy)
2023-05-03+6,134→ 6,134 total
Other
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-25−138,500→ 0 total
Other
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-25+138,500→ 386,932 total
Other
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-25−138,500→ 0 total
Other
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-25+138,500→ 386,932 total
Other
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-21+248,432→ 248,432 total
Purchase
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-21$3.72/sh+36,500→ 138,500 total
Other
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-21−248,432→ 147,255 total
Purchase
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-21$3.72/sh+36,500→ 138,500 total
Other
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-21+248,432→ 248,432 total
Other
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-21−248,432→ 87,735 total
Purchase
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-20$3.62/sh+52,000→ 102,000 total
Purchase
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-20$3.62/sh+52,000→ 102,000 total
Purchase
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-19$3.52/sh+50,000→ 50,000 total
Purchase
Tourmaline Bio, Inc.$TRML
Common Stock
2022-07-19$3.52/sh+50,000→ 50,000 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2022-06-09+14,501→ 14,501 total
Exercise/Conversion
Moderna, Inc.$MRNA
Stock Option (Right to Buy)
2022-05-10−23,100→ 16,620 total
Sale
Moderna, Inc.$MRNA
Common Stock
2022-05-10$136.10/sh−3,196→ 20,607 total
Exercise/Conversion
Moderna, Inc.$MRNA
Common Stock
2022-05-10$18.87/sh+23,100→ 23,803 total
Exercise/Conversion
Moderna, Inc.$MRNA
Common Stock
2022-04-28+703→ 703 total
Award
Moderna, Inc.$MRNA
Stock Option (Right to Buy)
2022-04-28+5,415→ 5,415 total
Exercise/Conversion
Moderna, Inc.$MRNA
Restricted Stock Units
2022-04-28−703→ 0 total
Gift
Tourmaline Bio, Inc.$TRML
Common Stock
2021-12-15−59,520→ 336,167 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−3,222→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−8,185→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−20,000→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−7,500→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−576→ 0 total
Disposition from Tender
ACCELERON PHARMA INC
Common Stock
2021-11-19−6,749→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−10,000→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−10,000→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−7,500→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−7,500→ 0 total
Disposition to Issuer
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2021-07-21−13,921→ 0 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2021-05-20+1,962→ 13,248 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2021-05-20+673→ 13,921 total
Award
Moderna, Inc.$MRNA
Restricted Stock Units
2021-04-28+703→ 703 total
Award
Moderna, Inc.$MRNA
Stock Option (Right to Buy)
2021-04-28+4,081→ 4,081 total
Award
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-01-29+3,222→ 3,222 total
Award
ACCELERON PHARMA INC
Common Stock
2021-01-29+1,622→ 6,749 total
Disposition to Issuer
Prevail Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-22−17,000→ 0 total
Disposition to Issuer
Prevail Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-22−133,447→ 0 total
Disposition to Issuer
Prevail Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-22−32,000→ 0 total
Disposition from Tender
Prevail Therapeutics Inc.
Common Stock
2021-01-22−23,747→ 0 total
Award
Prevail Therapeutics Inc.
Stock Option (Right to Buy)
2020-06-17+17,000→ 17,000 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2020-05-14+3,468→ 10,345 total

Companies

Recent Filings

Address

C/O NOVEN PHARMACEUTICALS, INC. 11960 SW 144TH ST.

MIAMI, FL, 33186

View on SEC.gov